INVESTOR ALERT: GPM Commences Investigation on Behalf of DaVita Healthcare Partners, Inc. Investors
February 12 2016 - 12:34PM
Business Wire
Glancy Prongay & Murray LLP (“GPM”) announces that it is
investigating potential claims on behalf of investors of DaVita
Healthcare Partners, Inc. ("DaVita" or the "Company") (NYSE:DVA),
concerning the Company and its officers’ possible violations of
federal securities laws and/or breaches of fiduciary duty.
Please contact Lesley Portnoy at 888-773-9224 or 310-201-9150,
or at shareholders@glancylaw.com to discuss this matter. If you
inquire by email, please include your mailing address, telephone
number, and number of shares purchased.
On February 11, 2016, post-market, the company disclosed that it
had received a Civil Investigative Demand (CID) from the U.S.
Attorney's Office for the Northern District of Texas regarding a
False Claims Act investigation into allegations that it submitted
false claims to the government for prescription drug reimbursement
dating back to January 1, 2006. On this news, the company's
shares fell $1.99, or 3.18%, to $60.58 post-market on February 11,
2016.
If you purchased shares of DaVita, have information or would
like to learn more about these claims, or have any questions
concerning this announcement or your rights or interests with
respect to these matters, please contact Lesley Portnoy, Esquire,
of Glancy Prongay & Murray LLP, 1925 Century Park East, Suite
2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at
888-773-9224, by email to shareholders@glancylaw.com, or visit our
website at http://www.glancylaw.com. If you inquire by email please
include your mailing address, telephone number and number of shares
purchased.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160212005653/en/
Glancy Prongay & Murray LLP, Los AngelesLesley Portnoy,
310-201-9150 or
888-773-9224shareholders@glancylaw.comwww.glancylaw.com
DaVita (NYSE:DVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Apr 2023 to Apr 2024